FRCS Revision

This site is private

Enter the password to open the revision library.

Personal revision library · not clinical advice
FRCSRevision
Home / Hip / THA - principles, consent and survivorship
Hip

THA - principles, consent and survivorship

Aims of hip replacement, implant longevity and pre-operative consent discussion

11 questions 3 source pages 1 fact-check flags

Images appear with the first question taken from each source page — tap a question to open it.

11 questions
Q1What is the goal of total hip replacement (THR)?▸
  • Painless, stable, mobile hip
Q2Which biomechanical parameters should be restored at THR?▸
  • Restore hip centre and offset
  • Equalization of LLD
  • Correct orientation of components
Q3What are the surgical principles of THR relating to leg length and soft tissues?▸
  • Equalization of LLD
  • Good soft tissue balance
Q4What registry data are referenced for total hip survival?▸
  • Refer to AONJRR
  • UK joint reg – revision at 15 yrs
  • AUS joint reg – revision at 15 yrs
Q5What are the 15-year revision rates for THR by fixation type in the UK joint registry?▸
  • Overall: cemented 4.85%, cementless 5%, hybrid 4%
  • <55: hybrid 4%, cementless 6%, cemented 7%
  • >75: cemented 2%, cementless 4%
Q6What are the 15-year revision rates in the AUS joint registry?▸
  • Overall: cemented 5.7%, cementless 6%, Hybrid 5.5 %
Q7What general and anaesthetic risks would you discuss when consenting for THR?▸
  • Anaesthesia risk --> CVA, AMI, death
  • Wound complications; bleeding requiring transfusion
  • Clinical DVT ~2%
  • UTI and chest infection ~10%
  • Mortality ~0.5% in hospital
Q8What thromboembolic risks are quoted for THR?▸
  • Symptomatic PE ~2.5%
  • Fatal PE <0.5%
Q9What are the intraoperative risks of THR?▸
  • Fracture: primary cement 1%, cementless 10%
  • Fracture: revision cement 3%, cementless 30%
  • Nerve palsy 1-3 %
  • Vascular injury 0.2%
  • LLD: 1.5 cm lengthening in 18%
Q10What are the postoperative risks of THR?▸
  • Infection ~1% (Lidwell BMJ 1982)
  • Dislocation 3%
  • HO 2-90%
  • Periprosthetic fracture
  • Loosening: 10-year survivorship ~90%
Q11What are the consent figures for revision THR?▸
  • Mortality 2.5% in 90 days
  • 1% not satisfied

Fact check

Consent for THR: clinical DVT ~2%, symptomatic PE ~2.5% and fatal PE <0.5% — outdated / higher than modern series — Contemporary THA data report symptomatic DVT ~0.3-0.6%, symptomatic PE ~0.2-0.5% and fatal PE ~0.03-0.1% with modern prophylaxis and early mobilisation — (medium confidence) — source